Securities and Exchange Commission
Washington, D.C. 20549
Form 6-K
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d/16 of
the Securities Exchange Act of 1934
May 2011
AEGON N.V.
AEGONplein 50
2591 TV THE HAGUE
The Netherlands
AEGONs press release, dated May 12, 2011, is included as appendix and incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AEGON N.V. | ||||||
(Registrant) | ||||||
Date: May 13, 2011 | By | /s/ E. Lagendijk | ||||
E. Lagendijk | ||||||
Executive Vice President and General Counsel |
Exhibit 99.1
AEGON announces Q1 2011 net income of EUR 327 million
| Underlying earnings growth in Americas and New Markets offset by declines in UK and Netherlands |
| Underlying earnings before tax of EUR 414 million; strong earnings from US pensions and variable annuities offset by exceptional charges in the UK (EUR 24 million) and higher provisioning for longevity in the Netherlands (EUR 24 million) |
| Net income of EUR 327 million, supported by lower impairments (EUR 62 million) and higher earnings from run-off businesses (EUR 22 million) |
| RoE declines to 7.8% as a result of lower net underlying earnings and higher average shareholders equity |
| Sales growth in fee-based businesses key area of focus |
| Total sales* of EUR 1,411 million |
| New life sales total EUR 501 million; higher sales in New Markets and the Netherlands offset by the UK |
| Gross deposits total EUR 7.4 billion, supported by strong US sales of pensions and variable annuities consistent with strategy to increase fee-based business |
| Continued strong capital position and cash flows |
| Excess capital** totaled EUR 3.7 billion, of which EUR 1.3 billion at the holding after repurchase of convertible core capital securities from Dutch State and equity issuance |
| IGDa) solvency ratio of 209% |
| Operational free cash flow of EUR 264 million |
Statement of Alex Wynaendts, CEO
We made solid progress on AEGONs strategic objectives during the quarter, which include the repurchase of EUR 750 million of core capital securities from the Dutch State in March. The recently announced divestment of AEGONs life reinsurance business further supports our aim to complete the repurchase of all remaining securities by the end of June. With these key achievements along with the other actions we have taken in recent years to optimize our portfolio of businesses we have established a new basis from which to pursue AEGONs ambitions.
During the first quarter, AEGONs businesses in the United States continued to show strong results, both in terms of earnings as well as sales. The strong sales of pensions and variable annuities clearly support our strategic shift to more fee-generating business. In the Netherlands, we have been observing a strong increase in life expectancy and are taking a prudent approach by now increasing our provisioning which will have an impact on the earnings of our Dutch business going forward. In the United Kingdom, we are confident that our new CEO and management team will fully deliver on our plans.
We were particularly pleased by the strong new life sales achieved by AEGONs newer businesses in Central & Eastern Europe and Asia. Over time, these key growth regions, in addition to Latin America, will enable us to achieve a broader geographical balance given the substantial opportunity they present.
KEY PERFORMANCE INDICATORS
amounts in EUR millions b) |
Notes | Q1 2011 | Q4 2010 | % | Q1 2010 | % | ||||||||||||||||||
Underlying earnings before tax |
1 | 414 | 452 | (8 | ) | 446 | (7 | ) | ||||||||||||||||
Net income |
2 | 327 | 318 | 3 | 372 | (12 | ) | |||||||||||||||||
Sales |
3 | 1,411 | 1,506 | (6 | ) | 1,442 | (2 | ) | ||||||||||||||||
Value of new business (VNB) |
4 | 118 | 129 | (9 | ) | 138 | (14 | ) | ||||||||||||||||
Return on equity |
5 | 7.8 | % | 8.7 | % | (10 | ) | 8.9 | % | (12 | ) |
For notes see page 20.
* | To reflect all of AEGONs sales in one sales indicator, AEGON introduced a composite sales number consisting of new life sales, new premium production of both accident & health insurance and general insurance and 1/10 of gross deposits. |
** | Excess capital above AA capital adequacy requirements. |
Note: The comparative 2010 underlying earnings and sales information has been revised to reflect the transfer of life reinsurance and BOLI/COLI businesses to the run-off businesses line to make the information consistent with current period figures.
Supplements: Financial Supplement and Condensed Consolidated Interim Financial Statements Q1 available on www.aegon.com
Page 1 of 22
STRATEGIC HIGHLIGHTS
| Announcement of divestment of Transamerica Reinsurance for a total consideration of USD 1.4 billion |
| Equity issuance of EUR 903 million |
| Repurchase of EUR 750 million convertible core capital securities from the Dutch State |
| Fully hedged US GMIB back-book and further reduced exposure to peripheral European sovereign bonds |
| Restructuring in the UK on track; appointment of Adrian Grace as CEO of AEGON UK |
Page 2 of 22
Page 3 of 22
FINANCIAL OVERVIEW c)
EUR millions |
Notes | Q1 2011 | Q4 2010 | % | Q1 2010 | % | ||||||||||||||||||
Underlying earnings before tax |
||||||||||||||||||||||||
Americas |
347 | 369 | (6 | ) | 337 | 3 | ||||||||||||||||||
The Netherlands |
81 | 87 | (7 | ) | 104 | (22 | ) | |||||||||||||||||
United Kingdom |
12 | (6 | ) | | 28 | (57 | ) | |||||||||||||||||
New markets |
57 | 59 | (3 | ) | 46 | 24 | ||||||||||||||||||
Holding and other |
(83 | ) | (57 | ) | (46 | ) | (69 | ) | (20 | ) | ||||||||||||||
Underlying earnings before tax |
414 | 452 | (8 | ) | 446 | (7 | ) | |||||||||||||||||
Fair value items |
(85 | ) | 30 | | (16 | ) | | |||||||||||||||||
Realized gains / (losses) on investments |
91 | 255 | (64 | ) | 126 | (28 | ) | |||||||||||||||||
Impairment charges |
(62 | ) | (133 | ) | 53 | (150 | ) | 59 | ||||||||||||||||
Other income / (charges) |
(3 | ) | (258 | ) | 99 | 23 | | |||||||||||||||||
Run-off businesses |
22 | 9 | 144 | (18 | ) | | ||||||||||||||||||
Income before tax |
377 | 355 | 6 | 411 | (8 | ) | ||||||||||||||||||
Income tax |
(50 | ) | (37 | ) | (35 | ) | (39 | ) | (28 | ) | ||||||||||||||
Net income |
327 | 318 | 3 | 372 | (12 | ) | ||||||||||||||||||
Net income / (loss) attributable to: |
||||||||||||||||||||||||
Equity holders of AEGON N.V. |
327 | 318 | 3 | 371 | (12 | ) | ||||||||||||||||||
Non-controlling interests |
| | | 1 | | |||||||||||||||||||
Net underlying earnings |
333 | 348 | (4 | ) | 345 | (3 | ) | |||||||||||||||||
Commissions and expenses |
1,513 | 1,659 | (9 | ) | 1,586 | (5 | ) | |||||||||||||||||
of which operating expenses |
11 | 837 | 909 | (8 | ) | 812 | 3 | |||||||||||||||||
New life sales |
||||||||||||||||||||||||
Life single premiums |
1,726 | 2,002 | (14 | ) | 1,919 | (10 | ) | |||||||||||||||||
Life recurring premiums annualized |
328 | 330 | (1 | ) | 311 | 5 | ||||||||||||||||||
Total recurring plus 1/10 single |
501 | 530 | (5 | ) | 503 | | ||||||||||||||||||
New life sales |
||||||||||||||||||||||||
Americas |
12 | 113 | 118 | (4 | ) | 110 | 3 | |||||||||||||||||
The Netherlands |
65 | 113 | (42 | ) | 62 | 5 | ||||||||||||||||||
United Kingdom |
247 | 224 | 10 | 265 | (7 | ) | ||||||||||||||||||
New markets |
12 | 76 | 75 | 1 | 66 | 15 | ||||||||||||||||||
Total recurring plus 1/10 single |
501 | 530 | (5 | ) | 503 | | ||||||||||||||||||
New premium production accident and health insurance |
159 | 180 | (12 | ) | 148 | 7 | ||||||||||||||||||
New premium production general insurance |
13 | 15 | (13 | ) | 14 | (7 | ) | |||||||||||||||||
Gross deposits (on and off balance) |
||||||||||||||||||||||||
Americas |
12 | 5,629 | 5,757 | (2 | ) | 5,402 | 4 | |||||||||||||||||
The Netherlands |
462 | 490 | (6 | ) | 743 | (38 | ) | |||||||||||||||||
United Kingdom |
19 | 25 | (24 | ) | 36 | (47 | ) | |||||||||||||||||
New markets |
12 | 1,267 | 1,541 | (18 | ) | 1,593 | (20 | ) | ||||||||||||||||
Total gross deposits |
7,377 | 7,813 | (6 | ) | 7,774 | (5 | ) | |||||||||||||||||
Net deposits (on and off balance) |
||||||||||||||||||||||||
Americas |
12 | (233 | ) | (566 | ) | 59 | 535 | | ||||||||||||||||
The Netherlands |
(115 | ) | (260 | ) | 56 | 67 | | |||||||||||||||||
United Kingdom |
2 | 12 | (83 | ) | 29 | (93 | ) | |||||||||||||||||
New markets |
12 | (1,719 | ) | 304 | | 121 | | |||||||||||||||||
Total net deposits excluding run-off businesses |
(2,065 | ) | (510 | ) | | 752 | | |||||||||||||||||
Run-off businesses |
(880 | ) | (1,436 | ) | 39 | (2,210 | ) | 60 | ||||||||||||||||
Total net deposits |
(2,945 | ) | (1,946 | ) | (51 | ) | (1,458 | ) | (102 | ) |
REVENUE-GENERATING INVESTMENTS
Mar. 31, 2011 |
Dec. 31, 2010 |
% | ||||||||||
Revenue-generating investments (total) |
399,882 | 413,191 | (3 | ) | ||||||||
Investments general account |
136,991 | 143,188 | (4 | ) | ||||||||
Investments for account of policyholders |
144,296 | 146,237 | (1 | ) | ||||||||
Off balance sheet investments third parties |
118,595 | 123,766 | (4 | ) |
Page 4 of 22
OPERATIONAL HIGHLIGHTS
Page 5 of 22
Page 6 of 22
Page 7 of 22
APPENDIX I Americas The Netherlands United Kingdom New Markets
AMERICAS c)
USD millions |
Notes | Q1 2011 | Q4 2010 | % | Q1 2010 | % | ||||||||||||||||||
Underlying earnings before tax by line of business |
||||||||||||||||||||||||
Life and protection |
195 | 242 | (19 | ) | 194 | 1 | ||||||||||||||||||
Fixed annuities |
90 | 81 | 11 | 121 | (26 | ) | ||||||||||||||||||
Variable annuities |
93 | 68 | 37 | 69 | 35 | |||||||||||||||||||
Retail mutual funds |
6 | 6 | | | | |||||||||||||||||||
Individual savings and retirement products |
189 | 155 | 22 | 190 | (1 | ) | ||||||||||||||||||
Employer solutions & pensions |
81 | 80 | 1 | 69 | 17 | |||||||||||||||||||
Canada |
11 | 15 | (27 | ) | 11 | | ||||||||||||||||||
Latin America |
(2 | ) | 2 | | 1 | | ||||||||||||||||||
Underlying earnings before tax |
474 | 494 | (4 | ) | 465 | 2 | ||||||||||||||||||
Fair value items |
(17 | ) | 10 | | (120 | ) | 86 | |||||||||||||||||
Realized gains / (losses) on investments |
35 | 327 | (89 | ) | 33 | 6 | ||||||||||||||||||
Impairment charges |
(80 | ) | (131 | ) | 39 | (191 | ) | 58 | ||||||||||||||||
Other income / (charges) |
| (264 | ) | | | | ||||||||||||||||||
Run-off businesses |
30 | 11 | 173 | (24 | ) | | ||||||||||||||||||
Income before tax |
442 | 447 | (1 | ) | 163 | 171 | ||||||||||||||||||
Income tax |
(83 | ) | (53 | ) | (57 | ) | 54 | | ||||||||||||||||
Net income |
359 | 394 | (9 | ) | 217 | 65 | ||||||||||||||||||
Net income / (loss) attributable to: |
||||||||||||||||||||||||
Equity holders of AEGON N.V. |
359 | 394 | (9 | ) | 217 | 65 | ||||||||||||||||||
Net underlying earnings |
346 | 361 | (4 | ) | 358 | (3 | ) | |||||||||||||||||
Commissions and expenses |
1,209 | 1,333 | (9 | ) | 1,355 | (11 | ) | |||||||||||||||||
of which operating expenses |
492 | 514 | (4 | ) | 501 | (2 | ) | |||||||||||||||||
New life sales |
12 | |||||||||||||||||||||||
Life single premiums |
147 | 194 | (24 | ) | 179 | (18 | ) | |||||||||||||||||
Life recurring premiums annualized |
139 | 139 | | 136 | 2 | |||||||||||||||||||
Total recurring plus 1/10 single |
154 | 158 | (3 | ) | 154 | | ||||||||||||||||||
Life & protection |
121 | 129 | (6 | ) | 121 | | ||||||||||||||||||
Employer solutions & pensions |
6 | 5 | 20 | 8 | (25 | ) | ||||||||||||||||||
Canada |
17 | 14 | 21 | 15 | 13 | |||||||||||||||||||
Latin America |
10 | 10 | | 10 | | |||||||||||||||||||
Total recurring plus 1/10 single |
154 | 158 | (3 | ) | 154 | | ||||||||||||||||||
New premium production accident and health insurance |
199 | 230 | (13 | ) | 184 | 8 | ||||||||||||||||||
Gross deposits (on and off balance) by line of business |
12 | |||||||||||||||||||||||
Life & protection |
3 | 2 | 50 | 3 | | |||||||||||||||||||
Fixed annuities |
83 | 112 | (26 | ) | 185 | (55 | ) | |||||||||||||||||
Variable annuities |
1,179 | 1,037 | 14 | 809 | 46 | |||||||||||||||||||
Retail mutual funds |
775 | 692 | 12 | 976 | (21 | ) | ||||||||||||||||||
Individual savings & retirement products |
2,037 | 1,841 | 11 | 1,970 | 3 | |||||||||||||||||||
Employer solutions & pensions |
5,554 | 5,744 | (3 | ) | 5,217 | 6 | ||||||||||||||||||
Canada |
97 | 102 | (5 | ) | 286 | (66 | ) | |||||||||||||||||
Total gross deposits |
7,691 | 7,689 | | 7,476 | 3 | |||||||||||||||||||
Net deposits (on and off balance) by line of business |
12 | |||||||||||||||||||||||
Life & protection |
(14 | ) | (14 | ) | | (15 | ) | 7 | ||||||||||||||||
Fixed annuities |
(801 | ) | (660 | ) | (21 | ) | (543 | ) | (48 | ) | ||||||||||||||
Variable annuities |
220 | 158 | 39 | (23 | ) | | ||||||||||||||||||
Retail mutual funds |
(50 | ) | (37 | ) | (35 | ) | 418 | | ||||||||||||||||
Individual savings & retirement products |
(631 | ) | (539 | ) | (17 | ) | (148 | ) | | |||||||||||||||
Employer solutions & pensions |
485 | (28 | ) | | 1,386 | (65 | ) | |||||||||||||||||
Canada |
(158 | ) | (156 | ) | (1 | ) | (482 | ) | 67 | |||||||||||||||
Total net deposits excluding run-off businesses |
(318 | ) | (737 | ) | 57 | 741 | | |||||||||||||||||
Run-off businesses |
(1,202 | ) | (1,927 | ) | 38 | (3,058 | ) | 61 | ||||||||||||||||
Total net deposits |
(1,520 | ) | (2,664 | ) | 43 | (2,317 | ) | 34 |
REVENUE-GENERATING INVESTMENTS
Mar. 31, 2011 |
Dec. 31, 2010 |
% | ||||||||||
Revenue-generating investments (total) |
324,849 | 319,733 | 2 | |||||||||
Investments general account |
124,185 | 125,128 | (1 | ) | ||||||||
Investments for account of policyholders |
82,459 | 79,308 | 4 | |||||||||
Off balance sheet investments third parties |
118,205 | 115,297 | 3 |
Page 8 of 22
AMERICAS
| Underlying earnings before tax increase to USD 474 million driven by pensions and variable annuities |
| Net income increases to USD 359 million |
| New life sales are stable at USD 154 million |
| Gross deposits increase to USD 7.7 billion driven by strong pension and variable annuity deposits |
Page 9 of 22
Page 10 of 22
THE NETHERLANDS
EUR millions |
Notes | Q1 2011 | Q4 2010 | % | Q1 2010 | % | ||||||||||||||||||
Underlying earnings before tax by line of business |
||||||||||||||||||||||||
Life and Savings |
43 | 54 | (20 | ) | 39 | 10 | ||||||||||||||||||
Pensions |
22 | 35 | (37 | ) | 47 | (53 | ) | |||||||||||||||||
Non life |
5 | 4 | 25 | 7 | (29 | ) | ||||||||||||||||||
Distribution |
11 | (3 | ) | | 11 | | ||||||||||||||||||
Share in underlying earnings before tax of associates |
| (3 | ) | | | | ||||||||||||||||||
Underlying earnings before tax |
81 | 87 | (7 | ) | 104 | (22 | ) | |||||||||||||||||
Fair value items |
(60 | ) | 18 | | 91 | | ||||||||||||||||||
Realized gains / (losses) on investments |
35 | 1 | | 96 | (64 | ) | ||||||||||||||||||
Impairment charges |
(2 | ) | | | (1 | ) | (100 | ) | ||||||||||||||||
Other income / (charges) |
(8 | ) | 5 | | | | ||||||||||||||||||
Income before tax |
46 | 111 | (59 | ) | 290 | (84 | ) | |||||||||||||||||
Income tax |
(7 | ) | (30 | ) | 77 | (67 | ) | 90 | ||||||||||||||||
Net income |
39 | 81 | (52 | ) | 223 | (83 | ) | |||||||||||||||||
Net income / (loss) attributable to: |
||||||||||||||||||||||||
Equity holders of AEGON N.V. |
39 | 81 | (52 | ) | 223 | (83 | ) | |||||||||||||||||
Net underlying earnings |
66 | 70 | (6 | ) | 77 | (14 | ) | |||||||||||||||||
Commissions and expenses |
272 | 283 | (4 | ) | 264 | 3 | ||||||||||||||||||
of which operating expenses |
189 | 205 | (8 | ) | 182 | 4 | ||||||||||||||||||
New life sales |
||||||||||||||||||||||||
Life single premiums |
457 | 737 | (38 | ) | 397 | 15 | ||||||||||||||||||
Life recurring premiums annualized |
19 | 39 | (51 | ) | 22 | (14 | ) | |||||||||||||||||
Total recurring plus 1/10 single |
65 | 113 | (42 | ) | 62 | 5 | ||||||||||||||||||
Life and Savings |
26 | 17 | 53 | 27 | (4 | ) | ||||||||||||||||||
Pensions |
39 | 96 | (59 | ) | 35 | 11 | ||||||||||||||||||
Total recurring plus 1/10 single |
65 | 113 | (42 | ) | 62 | 5 | ||||||||||||||||||
New premium production accident and health insurance |
10 | 6 | 67 | 11 | (9 | ) | ||||||||||||||||||
New premium production general insurance |
8 | 6 | 33 | 8 | | |||||||||||||||||||
Gross deposits (on and off balance) by line of business |
||||||||||||||||||||||||
Life and Savings |
382 | 403 | (5 | ) | 683 | (44 | ) | |||||||||||||||||
Pensions |
80 | 87 | (8 | ) | 60 | 33 | ||||||||||||||||||
Total gross deposits |
462 | 490 | (6 | ) | 743 | (38 | ) | |||||||||||||||||
Net deposits (on and off balance) by line of business |
||||||||||||||||||||||||
Life and Savings |
(142 | ) | (282 | ) | 50 | 82 | | |||||||||||||||||
Pensions |
27 | 22 | 23 | (15 | ) | | ||||||||||||||||||
Total net deposits |
(115 | ) | (260 | ) | 56 | 67 | |
REVENUE-GENERATING INVESTMENTS
Mar. 31, 2011 |
Dec. 31, 2010 |
% | ||||||||||
Revenue-generating investments (total) |
73,393 | 72,584 | 1 | |||||||||
Investments general account |
37,448 | 37,174 | 1 | |||||||||
Investments for account of policyholders |
23,627 | 23,057 | 2 | |||||||||
Off balance sheet investments third parties |
12,318 | 12,353 | |
Page 11 of 22
THE NETHERLANDS
| Underlying earnings before tax decrease to EUR 81 million due to higher provisioning for longevity |
| Net income decreases to EUR 39 million |
| New life sales increase to EUR 65 million mainly as a result of a large single premium pension contract |
Page 12 of 22
UNITED KINGDOM
GBP millions |
Notes | Q1 2011 | Q4 2010 | % | Q1 2010 | % | ||||||||||||||||||
Underlying earnings before tax by line of business |
||||||||||||||||||||||||
Life |
21 | 4 | | 18 | 17 | |||||||||||||||||||
Pensions |
(9 | ) | (8 | ) | (13 | ) | 9 | | ||||||||||||||||
Distribution |
(2 | ) | (2 | ) | | (2 | ) | | ||||||||||||||||
Underlying earnings before tax |
10 | (6 | ) | | 25 | (60 | ) | |||||||||||||||||
Fair value items |
(1 | ) | | | 2 | | ||||||||||||||||||
Realized gains / (losses) on investments |
25 | 7 | | 2 | | |||||||||||||||||||
Impairment charges |
| (20 | ) | | (7 | ) | | |||||||||||||||||
Other income / (charges) |
7 | (5 | ) | (11 | ) | 55 | 21 | | ||||||||||||||||
Income before tax |
29 | (30 | ) | | 43 | (33 | ) | |||||||||||||||||
Income tax attributable to policyholder return |
(1 | ) | 6 | | (21 | ) | 95 | |||||||||||||||||
Income before income tax on shareholders return |
28 | (24 | ) | | 22 | 27 | ||||||||||||||||||
Income tax on shareholders return |
18 | 8 | 125 | (2 | ) | | ||||||||||||||||||
Net income |
46 | (16 | ) | | 20 | 130 | ||||||||||||||||||
Net income / (loss) attributable to: |
||||||||||||||||||||||||
Equity holders of AEGON N.V. |
46 | (16 | ) | | 20 | 130 | ||||||||||||||||||
Net underlying earnings |
33 | (2 | ) | | 22 | 50 | ||||||||||||||||||
Commissions and expenses |
172 | 164 | 5 | 170 | 1 | |||||||||||||||||||
of which operating expenses |
98 | 98 | | 95 | 3 | |||||||||||||||||||
New life sales |
8 | |||||||||||||||||||||||
Life single premiums |
841 | 798 | 5 | 1,139 | (26 | ) | ||||||||||||||||||
Life recurring premiums annualized |
127 | 110 | 15 | 121 | 5 | |||||||||||||||||||
Total recurring plus 1/10 single |
211 | 190 | 11 | 235 | (10 | ) | ||||||||||||||||||
Life |
16 | 15 | 7 | 26 | (38 | ) | ||||||||||||||||||
Pensions |
195 | 175 | 11 | 209 | (7 | ) | ||||||||||||||||||
Total recurring plus 1/10 single |
211 | 190 | 11 | 235 | (10 | ) | ||||||||||||||||||
Gross deposits (on and off balance) by line of business |
||||||||||||||||||||||||
Variable annuities |
17 | 21 | (19 | ) | 32 | (47 | ) | |||||||||||||||||
Total gross deposits |
17 | 21 | (19 | ) | 32 | (47 | ) | |||||||||||||||||
Net deposits (on and off balance) by line of business |
||||||||||||||||||||||||
Variable annuities |
2 | 10 | (80 | ) | 25 | (92 | ) | |||||||||||||||||
Total net deposits |
2 | 10 | (80 | ) | 25 | (92 | ) |
REVENUE-GENERATING INVESTMENTS
Mar. 31, 2011 |
Dec. 31, 2010 |
% | ||||||||||
Revenue-generating investments (total) |
57,717 | 57,641 | | |||||||||
Investments general account |
7,855 | 7,979 | (2 | ) | ||||||||
Investments for account of policyholders |
49,862 | 49,662 | |
Page 13 of 22
UNITED KINGDOM
| Underlying earnings before tax decrease to GBP 10 million as a result of exceptional charges |
| Net income increases to GBP 46 million |
| New life sales decrease to GBP 211 million as a result of lower annuity sales |
Page 14 of 22
NEW MARKETS
EUR millions |
Notes | Q1 2011 | Q4 2010 | % | Q1 2010 | % | ||||||||||||||||||
Underlying earnings before tax |
||||||||||||||||||||||||
Central Eastern Europe |
26 | 29 | (10 | ) | 27 | (4 | ) | |||||||||||||||||
Asia |
(11 | ) | (12 | ) | 8 | (6 | ) | (83 | ) | |||||||||||||||
Spain & France |
23 | 24 | (4 | ) | 20 | 15 | ||||||||||||||||||
Variable Annuities Europe |
5 | 4 | 25 | (2 | ) | | ||||||||||||||||||
AEGON Asset Management |
14 | 14 | | 7 | 100 | |||||||||||||||||||
Underlying earnings before tax |
57 | 59 | (3 | ) | 46 | 24 | ||||||||||||||||||
Fair value items |
| | | 3 | | |||||||||||||||||||
Realized gains / (losses) on investments |
2 | | | 3 | (33 | ) | ||||||||||||||||||
Impairment charges |
(2 | ) | (11 | ) | 82 | (2 | ) | | ||||||||||||||||
Other income / (charges) |
11 | (40 | ) | | | | ||||||||||||||||||
Income before tax |
68 | 8 | | 50 | 36 | |||||||||||||||||||
Income tax |
(26 | ) | 1 | | (13 | ) | (100 | ) | ||||||||||||||||
Net income |
42 | 9 | | 37 | 14 | |||||||||||||||||||
Net income / (loss) attributable to: |
||||||||||||||||||||||||
Equity holders of AEGON N.V. |
42 | 9 | | 36 | 17 | |||||||||||||||||||
Non-controlling interests |
| | | 1 | | |||||||||||||||||||
Net underlying earnings |
38 | 49 | (22 | ) | 32 | 19 | ||||||||||||||||||
Commissions and expenses |
180 | 216 | (17 | ) | 175 | 3 | ||||||||||||||||||
of which operating expenses |
141 | 168 | (16 | ) | 133 | 6 | ||||||||||||||||||
New life sales |
12 | |||||||||||||||||||||||
Life single premiums |
174 | 176 | (1 | ) | 108 | 61 | ||||||||||||||||||
Life recurring premiums annualized |
59 | 58 | 2 | 55 | 7 | |||||||||||||||||||
Total recurring plus 1/10 single |
76 | 75 | 1 | 66 | 15 | |||||||||||||||||||
Life |
62 | 60 | 3 | 53 | 17 | |||||||||||||||||||
Associates |
14 | 15 | (7 | ) | 13 | 8 | ||||||||||||||||||
Total recurring plus 1/10 single |
76 | 75 | 1 | 66 | 15 | |||||||||||||||||||
Central Eastern Europe |
27 | 27 | | 19 | 42 | |||||||||||||||||||
Asia |
11 | 9 | 22 | 10 | 10 | |||||||||||||||||||
Spain & France |
38 | 39 | (3 | ) | 37 | 3 | ||||||||||||||||||
Total recurring plus 1/10 single |
76 | 75 | 1 | 66 | 15 | |||||||||||||||||||
New premium production accident and health insurance |
3 | 2 | 50 | 4 | (25 | ) | ||||||||||||||||||
New premium production general insurance |
5 | 9 | (44 | ) | 6 | (17 | ) | |||||||||||||||||
Gross deposits (on and off balance) |
12 | |||||||||||||||||||||||
Central Eastern Europe |
182 | 231 | (21 | ) | 226 | (19 | ) | |||||||||||||||||
Asia |
11 | 10 | 10 | 44 | (75 | ) | ||||||||||||||||||
Spain & France |
8 | 23 | (65 | ) | 25 | (68 | ) | |||||||||||||||||
Variable Annuities Europe |
131 | 133 | (2 | ) | 188 | (30 | ) | |||||||||||||||||
AEGON Asset Management |
935 | 1,144 | (18 | ) | 1,110 | (16 | ) | |||||||||||||||||
Total gross deposits |
1,267 | 1,541 | (18 | ) | 1,593 | (20 | ) | |||||||||||||||||
Net deposits (on and off balance) |
12 | |||||||||||||||||||||||
Central Eastern Europe |
108 | 140 | (23 | ) | 69 | 57 | ||||||||||||||||||
Asia |
11 | 8 | 38 | 25 | (56 | ) | ||||||||||||||||||
Spain & France |
(11 | ) | 4 | | 25 | | ||||||||||||||||||
Variable Annuities Europe |
26 | 40 | (35 | ) | 79 | (67 | ) | |||||||||||||||||
AEGON Asset Management |
(1,853 | ) | 112 | | (77 | ) | | |||||||||||||||||
Total net deposits |
(1,719 | ) | 304 | | 121 | | ||||||||||||||||||
REVENUE-GENERATING INVESTMENTS
Mar. 31, 2011 |
Dec. 31, 2010 |
% | ||||||||||
Revenue-generating investments (total) |
32,211 | 34,075 | (5 | ) | ||||||||
Investments general account |
2,926 | 2,810 | 4 | |||||||||
Investments for account of policyholders |
6,210 | 6,139 | 1 | |||||||||
Off balance sheet investments third parties |
23,075 | 25,126 | (8 | ) |
Page 15 of 22
NEW MARKETS
| Underlying earnings before tax increase 24% to EUR 57 million |
| Net income increases 14% to EUR 42 million |
| New life sales increase to EUR 76 million, driven by strong recurring premium sales in CEE |
Page 16 of 22
Page 17 of 22
FINANCIAL OVERVIEW, Q1 2011 GEOGRAPHICALLY c)
EUR millions |
Americas | The Netherlands |
United Kingdom |
New Markets |
Holding, other activities & eliminations |
Total | ||||||||||||||||||
Underlying earnings before tax by line of business |
||||||||||||||||||||||||
Life |
150 | 43 | 24 | 19 | | 236 | ||||||||||||||||||
Individual savings and retirement products |
139 | | | | | 139 | ||||||||||||||||||
Pensions |
59 | 22 | (10 | ) | 3 | | 74 | |||||||||||||||||
Non-life |
| 5 | | 11 | | 16 | ||||||||||||||||||
Distribution |
| 11 | (2 | ) | | | 9 | |||||||||||||||||
Asset Management |
| | | 14 | | 14 | ||||||||||||||||||
Other |
| | | | (83 | ) | (83 | ) | ||||||||||||||||
Share in underlying earnings before tax of associates |
(1 | ) | | | 10 | | 9 | |||||||||||||||||
Underlying earnings before tax |
347 | 81 | 12 | 57 | (83 | ) | 414 | |||||||||||||||||
Fair value items |
(12 | ) | (60 | ) | (1 | ) | | (12 | ) | (85 | ) | |||||||||||||
Realized gains / (losses) on investments |
25 | 35 | 29 | 2 | | 91 | ||||||||||||||||||
Impairment charges |
(58 | ) | (2 | ) | | (2 | ) | | (62 | ) | ||||||||||||||
Other income / (charges) |
| (8 | ) | (6 | ) | 11 | | (3 | ) | |||||||||||||||
Run-off businesses |
22 | | | | | 22 | ||||||||||||||||||
Income before tax |
324 | 46 | 34 | 68 | (95 | ) | 377 | |||||||||||||||||
Income tax |
(61 | ) | (7 | ) | 20 | (26 | ) | 24 | (50 | ) | ||||||||||||||
Net income |
263 | 39 | 54 | 42 | (71 | ) | 327 | |||||||||||||||||
Net underlying earnings |
253 | 66 | 39 | 38 | (63 | ) | 333 |
EMPLOYEE NUMBERS
Mar. 31, 2011 |
Dec. 31, 2010 |
|||||||
Employees excluding agents |
23,990 | 24,408 | ||||||
Agents |
2,990 | 3,066 | ||||||
Total number of employees excluding Associates |
26,980 | 27,474 | ||||||
AEGONs share of employees (including agents) in Associates |
3,932 | 3,680 | ||||||
Total |
30,912 | 31,154 | ||||||
Page 18 of 22
APPENDIX II
VALUE OF NEW BUSINESS AND IRR
VNB | VNB | VNB | ||||||||||||||||||
EUR millions, after tax |
Q1 2011 | Q4 2010 | % | Q1 2010 | % | |||||||||||||||
Americas |
63 | 53 | 19 | 44 | 43 | |||||||||||||||
The Netherlands |
23 | 42 | (45 | ) | 49 | (53 | ) | |||||||||||||
United Kingdom |
9 | 9 | | 14 | (36 | ) | ||||||||||||||
New Markets |
23 | 25 | (8 | ) | 31 | (26 | ) | |||||||||||||
Total |
118 | 129 | (9 | ) | 138 | (14 | ) |
IRR % | IRR% | IRR% | ||||||||||
EUR millions, after tax |
Q1 2011 | Q4 2010 | Q1 2010 | |||||||||
Americas |
16.0 | 13.9 | 12.6 | |||||||||
The Netherlands |
13.9 | 10.9 | 19.2 | |||||||||
United Kingdom |
10.0 | 10.1 | 10.7 | |||||||||
New Markets |
35.1 | 36.3 | 34.2 | |||||||||
Total |
18.8 | 16.8 | 19.3 |
MODELED NEW BUSINESS, APE AND DEPOSITS
Premium business APE |
||||||||||||||||||||||||
EUR millions |
Notes | Q1 2011 | Q4 2010 | % | Q1 2010 | % | ||||||||||||||||||
9 | ||||||||||||||||||||||||
Americas |
248 | 265 | (6 | ) | 216 | 15 | ||||||||||||||||||
The Netherlands |
75 | 188 | (60 | ) | 93 | (19 | ) | |||||||||||||||||
United Kingdom |
237 | 225 | 5 | 265 | (11 | ) | ||||||||||||||||||
New Markets |
95 | 99 | (4 | ) | 80 | 19 | ||||||||||||||||||
Total |
655 | 776 | (16 | ) | 654 | | ||||||||||||||||||
Deposit business Deposits |
||||||||||||||||||||||||
EUR millions |
Notes | Q1 2011 | Q4 2010 | % | Q1 2010 | % | ||||||||||||||||||
9 | ||||||||||||||||||||||||
Americas |
4,636 | 3,483 | 33 | 3,926 | 18 | |||||||||||||||||||
United Kingdom |
19 | 24 | (21 | ) | 34 | (44 | ) | |||||||||||||||||
New Markets |
216 | 219 | (1 | ) | 307 | (30 | ) | |||||||||||||||||
Total |
4,871 | 3,726 | 31 | 4,267 | 14 |
VNB/PVNBP SUMMARY
Premium business | ||||||||||||||||||||
VNB | PVNBP | VNB / PVNBP |
VNB / APE |
|||||||||||||||||
EUR millions |
Notes | Q1 2011 | % | % | ||||||||||||||||
10 | ||||||||||||||||||||
Americas |
30 | 826 | 3.7 | 12.2 | ||||||||||||||||
The Netherlands |
23 | 637 | 3.7 | 31.2 | ||||||||||||||||
United Kingdom |
9 | 1,489 | 0.6 | 3.8 | ||||||||||||||||
New Markets |
22 | 694 | 3.1 | 22.8 | ||||||||||||||||
Total |
84 | 3,646 | 2.3 | 12.9 |
Deposit business | ||||||||||||||||||||
VNB | PVNBP | VNB / PVNBP |
VNB / Deposits |
|||||||||||||||||
EUR millions |
Notes | Q1 2011 | % | % | ||||||||||||||||
10 | ||||||||||||||||||||
Americas |
33 | 6,477 | 0.5 | 0.7 | ||||||||||||||||
United Kingdom |
0 | 19 | 0.5 | 0.5 | ||||||||||||||||
New Markets |
1 | 316 | 0.3 | 0.5 | ||||||||||||||||
Total |
34 | 6,812 | 0.5 | 0.7 |
Page 19 of 22
Notes:
1) | For segment reporting purposes underlying earnings before tax, net underlying earnings, commissions and expenses, operating expenses, income tax including associated companies, income before tax including associated companies and value of new business (VNB) are calculated by consolidating on a proportionate basis the revenues and expenses of certain of our associated companies in Spain, India, Brazil and Mexico. We believe that our non-IFRS measures provide meaningful information about the underlying operating results of our business including insight into the financial measures that our senior management uses in managing our business. Among other things our senior management is compensated based in part on AEGONs results against targets using the non-IFRS measures presented here. While other insurers in our peer group present substantially similar non-IFRS measures, the non-IFRS measures presented in this document may nevertheless differ from the non-IFRS measures presented by other insurers. There is no standardized meaning to these measures under IFRS or any other recognized set of accounting standards and readers are cautioned to consider carefully the different ways in which we and our peers present similar information before comparing them. AEGON believes the non-IFRS measures shown herein, when read together with our reported IFRS financial statements, provide meaningful supplemental information for the investing public to evaluate AEGONs business after eliminating the impact of current IFRS accounting policies for financial instruments and insurance contracts, which embed a number of accounting policy alternatives that companies may select in presenting their results (i.e. companies can use different local GAAPs) and that can make the comparability from period to period difficult. For a definition of underlying earnings and the reconciliation from underlying earnings before tax to income before tax we refer to Note 3 Segment information of our Condensed consolidated interim financial statements. |
2) | Net income refers to net income attributable to equity holders of AEGON N.V. and minority interest. |
3) | Sales is defined as new recurring premiums plus 1/10 of single premiums plus 1/10 of gross deposits plus new premium production accident and health plus new premium production general insurance. |
4) | The present value of future distributable earnings on the block of business sold in the reporting period. Value of new business is calculated using beginning of year economic assumptions and assumptions outside of management control, and beginning of quarter operating assumptions |
5) | Return on equity is calculated by dividing the net underlying earnings after cost of leverage by the average shareholders equity excluding the preferred shares and the revaluation reserve. |
6) | Capital securities that are denominated in foreign currencies are, for purposes of calculating the capital base ratio, revalued to the period-end exchange rate. All ratios exclude AEGONs revaluation reserve. |
7) | Included in other income/(charges) are charges made to policyholders with respect to income tax in the United Kingdom. |
8) | Includes production on investment contracts without a discretionary participation feature of which the proceeds are not recognized as revenues but are directly added to our investment contract liabilities. |
9) | APE = recurring premium + 1/10 single premium. |
10) | PVNBP: Present Value New Business Premium. |
11) | Reconciliation of operating expenses, used for segment reporting, to our IFRS based operating expenses. |
Q1 2011 | ||||
Employee expenses |
537 | |||
Administrative expenses |
284 | |||
Operating expenses for IFRS reporting |
821 | |||
Operating expenses related to associates |
16 | |||
Operating expenses in earnings release |
837 |
12) | New life sales, gross deposits and net deposits data include results of our associated companies in Spain, India, Brazil and Mexico which are consolidated on a proportionate basis. |
13) | Operational free cash flow reflect the sum of the return on free surplus, earnings on in-force business, release on required surplus on in-force business reduced by new business first year strain and required surplus on new business. Refer to our Embedded Value 2010 report for further details. |
a) | The calculation of the IGD (Insurance Group Directive) capital surplus and ratio are based on Solvency I capital requirements on IFRS for entities within the EU (Pillar 1 for AEGON UK), and local regulatory solvency measurements for non-EU entities. Specifically, required capital for the life insurance companies in the US is calculated as two times the upper end of the Company Action Level range (200%) as applied by the National Association of Insurance Commissioners in the US. The calculation of the IGD ratio excludes the available and required capital of the UK With-Profit funds. In the UK solvency surplus calculation the local regulator only allows the available capital number of the With-Profit funds included in overall local available capital to be equal to the amount of With-Profit funds required capital. |
b) | The results in this release are unaudited. |
c) | The comparative 2010 earnings and sales information has been revised to reflect the transfer of the Life Reinsurance and BOLI/COLI businesses to the Run-off businesses line to make the information consistent with the current period figures. |
Currencies
Income statement items: average rate 1 EUR = USD 1.3663 (2010: USD 1.3838).
Income statement items: average rate 1 EUR = GBP 0.8523 (2010: GBP 0.8865).
Balance sheet items: closing rate 1 EUR = USD 1.4207 (2010: USD 1.3479; year-end 2010: USD 1.3362).
Balance sheet items: closing rate 1 EUR = GBP 0.8837 (2010: GBP 0.8898; year-end 2010: GBP 0.8608).
Page 20 of 22
ADDITIONAL INFORMATION
The Hague, May 12, 2011
Press conference call
8:00 am CET: Audio webcast on www.aegon.com
Analyst & investor presentation / conference call
9:00 am CET: Audio webcast on www.aegon.com
Call-in numbers
USA: | +1 480 629 9726 | |
UK: | + 44 207 153 2027 | |
NL: | +31 45 631 6901 |
Replay
Two hours after the conference call, a replay will be available on www.aegon.com and on the following phone numbers:
UK +44 207 154 2833 Access Code: 4434477#
US +1 303 590 3030 Access Code: 4434477#
Supplements
AEGONs Q1 2011 Financial Supplement and Condensed Consolidated Interim Financial Statements and the Embedded Value Report 2010 are available on www.aegon.com.
About AEGON
As an international life insurance, pension and asset management company based in The Hague, AEGON has businesses in over twenty markets in the Americas, Europe and Asia. AEGON companies employ approximately 27,000 people and have some 40 million customers across the globe. |
|
Contact information
Media relations:
Greg Tucker
+31(0)70 344 8956
gcc-ir@aegon.com | ||||||||
Key figures - EUR |
First quarter 2011 | Full year 2010 |
Investor relations:
Willem van den Berg
+31 (0)70 344 8305
877 548 9668 toll free USA only
ir@aegon.com
www.aegon.com | |||||||
Underlying earnings before tax |
414 million | 1.8 billion | ||||||||
New life sales |
501 million | 2.1 billion | ||||||||
Gross deposits |
7.4 billion | 33 billion | ||||||||
Revenue-generating investments (end of period) |
400 billion | 413 billion |
Page 21 of 22
Cautionary note regarding non-GAAP measures
This document includes certain non-GAAP financial measures: underlying earnings before tax and value of new business. The reconciliation of underlying earnings before tax to the most comparable IFRS measure is provided in Note 3 Segment information of our Condensed consolidated interim financial statements. Value of new business is not based on IFRS, which are used to report AEGONs primary financial statements and should not viewed as a substitute for IFRS financial measures. We may define and calculate value of new business differently than other companies. Please see AEGONs Embedded Value Report dated May 12, 2011 for an explanation of how we define and calculate. AEGON believes that these non-GAAP measures, together with the IFRS information, provide a meaningful measure for the investment community to evaluate AEGONs business relative to the businesses of our peers.
Local currencies and constant currency exchange rates
This document contains certain information about our results and financial condition in USD for the Americas and GBP for the United Kingdom, because those businesses operate and are managed primarily in those currencies. Certain comparative information presented on a constant currency basis eliminates the effects of changes in currency exchange rates. None of this information is a substitute for or superior to financial information about us presented in EUR, which is the currency of our primary financial statements.
Forward-looking statements
The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to our company. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. We undertake no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:
| Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom; |
| Changes in the performance of financial markets, including emerging markets, such as with regard to: |
| The frequency and severity of defaults by issuers in our fixed income investment portfolios; and |
| The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities we hold; |
| The frequency and severity of insured loss events; |
| Changes affecting mortality, morbidity, persistence and other factors that may impact the profitability of our insurance products; |
| Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels; |
| Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates; |
| Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets; |
| Changes in laws and regulations, particularly those affecting our operations, the products we sell, and the attractiveness of certain products to our consumers; |
| Regulatory changes relating to the insurance industry in the jurisdictions in which we operate; |
| Acts of God, acts of terrorism, acts of war and pandemics; |
| Changes in the policies of central banks and/or governments; |
| Lowering of one or more of our debt ratings issued by recognized rating organizations and the adverse impact such action may have on our ability to raise capital and on our liquidity and financial condition; |
| Lowering of one or more of insurer financial strength ratings of our insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability of its insurance subsidiaries and liquidity; |
| The effect of the European Unions Solvency II requirements and other regulations in other jurisdictions affecting the capital we are required to maintain; |
| Litigation or regulatory action that could require us to pay significant damages or change the way we do business; |
| Customer responsiveness to both new products and distribution channels; |
| Competitive, legal, regulatory, or tax changes that affect the distribution cost of or demand for our products; |
| The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including our ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions; |
| Our failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving initiatives; |
| Our inability to obtain consent from the Dutch Central Bank to repurchase our Core Capital Securities; and |
| The non-fulfillment of the conditions precedent underlying the agreement to divest Transamerica Reinsurance. |
Further details of potential risks and uncertainties affecting the company are described in the companys filings with Euronext Amsterdam and the US Securities and Exchange Commission, including the Annual Report on Form 20-F. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the companys expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Page 22 of 22
M'?)C3E^RNO@^U>T0M68[R=E_;"Z1X1S)D?YI3[@+P[Y,:[ON$ZL-(V1H
MKCC$Z"$QF'Y`A*E]8\BKFE0_R@3RWKAMSZU)4S@8%@0C;@'IS@"$2>/RF6OX
M5:7Z?;3<%N))S7'-Q]N^R%JCR(TN/9":S(M)2`NSJGL>B46%YR;BO8!GEN&^\
M\/Y[8BYE?A<,@\5A0)F;:\,
2"[V6&'#8","W$--"Z=.R]X*Q$K
MUSN0PJ?2(<4B'+`NS888X0H>!9";@X`Q'9WO(P<'D%POQRQ`-'V3=H35?IVV
MVG^(SZ,X[A:=]G[HJ]_`8>.3^JV++TOB?&N*/B-?48#2X
M@?T(4&'!S8>H#WXY7*[\"L?],;(]4Y-R#DS(;F4^,0`3Z%T6(Z)E!]"6AO
MS8>F9OXA07MO:E\#Z7MUO<2F6H#)L
WG&^(;6\I=_&MENUQ#DO,K)\5D.,2<6
XJV+U[A="$!8$5W0XZZGT0A"$KU?+:UK6M:
MO.+GU+IM$YO5J/1SFI
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end
GOEYW#J?+9M=FH7%APIDE+B9R5(#&129]4,3 MKYYVLNZGA_\`".>_B)IB>I&U^."Y?(Q(W%*$EHYG?*:9=ZV*'=2;2,E/QQ4^ M13!_74^8>7BC&Z6CGM`:UJ;`ZVZBA#25MK4$@E)Z0%$"2@1FE.M.UGFEM7*58$8C-(S!Z/8<(LWIYN"^RUD#6_"UV\-;/8XIM[D,;46? MS]<,-8X 5 *CSYC'8JMP5FP9T]<&,F<&3,>W''K$M0B\: MQ]?(TIAB$A#P3&=OSF5.W!`6ZJK=J0Y#(IE("$>AUIMO>@%=\\$UVVUPWLIC MK,NGV5H ,L0UJV3',Z;F047CXQHJ M]-WO:K*%5,`B8>$(LKFK?3)EXZ$&_P!TM]Q5G4-NYT];1A['KQO/N5#RF2<, M5O-5-@ZU8X]=T85YMU44$T&KAP!C_&8MQ'NP$P+'$J$60[BW\$/^IA[+U3^M M^YZWH_?X0@^G7UP":[Z\TC/<6W[\SA2U_- <`H+HWW2522"@'#HF9<.B*:^K[1Z;OH:FU M4R@JKK6[)4ACRJ5^P#F)[8Y#_3[O'1UAE!2'V%!3@FF0Q.!_='-53JZU*4I4 MV&&QYAF?CE+E]LE'#J@Y>K&ZFLNG>@CVGG@*CL+FC-V17C_*N%9HDJPA6%1` MBS")1LD@Z@7<5(-V47$H'*W3%8AUWIN\)>Z/.I.M=J]=;E[Q%ZI>JK19:)@& MGK2DR#@(^B>9,U92[P/=PBXNW6[>@=LME5TZZ>GN=ZN#ZC4TA4G%LSF'A(D) M[Q!F"/NB<\4YEPMU2M;-Q>G/#:TXZUO ^`>8# M ((J5J29P$J]G&SQMAJ,/&?'6R %:[VZB8, MQCCO(N%[2[C6"&5:[6*:G'/85%^\D6E>?3#%O+2D,^8K.VZ<@P7(+=P"J*8' M0BJ^T=Z\0CUG<9L]$Y#IX->GOA^^2$`UV1S7D.RR"D9*UN&DVDD[B8)*75:2 M[VO+NVJ;@S&,0DG3\R!$#O$D3*&,A$Y=0'I%9JI&7/#]8OT]P]<,G8,T&NR; M/+%[9NZPS&N1)+WB">E[M8T)2:BW"KVROXB7E5TVB*XE.8X`'/D`H0V/$Z]# M3+>YS^F[EZ.8]>W#8@K=EB[.6-*R^BH"4RK0S]PU4N0K3,E#13R6I2K 9N8"B9IRX0CT_^/'=#_P!?+5_UR_J>_+:U^ 'SI@S*V'YLI18Y#HU@K95#\N3:0>L%OFA\',#""L?*D16+R#O "1CATQ\MJ^QTFH=+UUAJYEAZF6"I M(!/-(E,I@B .L+WRX3]:G)"LV!S&P3I"`C9B&D%H>1 M"0LLB#.#:I)NVAS`(K=X2>7N^7CK)7[K:"M]D8N-UNS+:76$**"E7.%%(F$A M(F1.?`^Z./=!M3KJ\7ZJLEFM]8[Y=2I*'%A*$\LR0<4I!PXY07/"?A_]@[.N MP?YURC2\3Q!@3,O!U4J^0+8":AN:J`N3'BZTQ4,7R&[JKLH&'R K M+3-I<<8TM1.UE3^FZXEQ+?-TD3"@/:!%C=*^CO554A'_`%]>U34:R`XVA396 M4',`@*$Y=<')U3Z6NJ>HD_&WVB0MCL^48QB[9M\AW.>
\Q\H\5EW#WSUQK^E-OO3R&;$5?1:;PGA+O*"E'$#C+ MJBV&W.P.@-M*L7"Q-+?OH3+S''!_:GE'3TQ`FQ^!^N%9,UWR=U7WQU'QS@.3 M?LG./J+D_6AW;KQ5F'S1'I243-6=BJ*$X'SXFZ61<"!5/8*D(8.9!$8D;\`Q M4KK4)'W2'W91.`7SCFDD'Y<1AATGMQSG$'_5O\21^LET'_1*F?N\9PA?5O\` M$D?K)=!_T2IG[O"$:QUN\2?YNI%H+^B=-?T(\(1C]6[Q*/ZR/07]$^9_N_"$ M/W%>O_B#8C)E`E,N]0'2&W8KCK?`/ \CJ'J]H^ MIZO:/9Z?=]/'DYQ[&_!\.9RRS^T^N,N/$9PN$(7"$8#V_>?9[>$(S#L#[79] /CA"$'8'VNS['"$+A"/_9 ` end